Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024.
Merdrignac L, Laniece Delaunay C, Verdasca N, Vega-Piris L, O'Donnell J, Sève N, Trobajo-Sanmartín C, Buda S, Hooiveld M, Rodrigues AP, Túri G, Latorre-Margalef N, Mlinarić I, Lazar M, Maurel M, Castrillejo D, Bennett C, Rameix-Welti MA, Martínez-Baz I, Dürrwald R, Meijer A, Melo A, Oroszi B, Hagey TS, Kurečić Filipović S, Dijkstra F, Gomez V, Bacci S, Kaczmarek M, Kissling E; VEBIS Primary Care Vaccine Effectiveness Group. Merdrignac L, et al. Among authors: vega piris l. Influenza Other Respir Viruses. 2024 Nov;18(11):e70009. doi: 10.1111/irv.70009. Influenza Other Respir Viruses. 2024. PMID: 39523781 Free PMC article.
Effectiveness of influenza vaccines in children aged 6 to 59 months: a test-negative case-control study at primary care and hospital level, Spain 2023/24.
Pérez-Gimeno G, Mazagatos C, Lorusso N, Basile L, Martínez-Pino I, Corpas Burgos F, Batalla Rebolla N, Rumayor Zarzuelo MB, Andreu Ivorra B, Giménez Duran J, Castrillejo D, Guiu Cañete I, Huerta Huerta M, García Becerril M, Ramos Marín V, Casas I, Pozo F, Monge S; SiVIRA group; Members of the SiVIRA sentinel surveillance study group. Pérez-Gimeno G, et al. Euro Surveill. 2024 Oct;29(40):2400618. doi: 10.2807/1560-7917.ES.2024.29.40.2400618. Euro Surveill. 2024. PMID: 39364601 Free PMC article.
Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years.
Vega-Piris L, Carretero SG, Mayordomo JL, Zarzuelo MBR, Río VÁ, García VG, Vázquez MG, Rodríguez MDCG, Basile L, González-Coviella NL, Boada MIB, Pérez-Martínez O, Azevedo AL, Rubio CQ, Duran JG, Ibáñez AF, Rivera MVG, Marín VR, Castrillejo D, Raymundo LJV, Larrauri A, Monge S; SARI Sentinel Surveillance Group. Vega-Piris L, et al. J Infect. 2024 Nov;89(5):106292. doi: 10.1016/j.jinf.2024.106292. Epub 2024 Sep 26. J Infect. 2024. PMID: 39341402 Free article.
Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination.
Varea-Jiménez E, Aznar Cano E, Vega-Piris L, Martínez Sánchez EV, Mazagatos C, García San Miguel Rodríguez-Alarcón L, Casas I, Sierra Moros MJ, Iglesias-Caballero M, Vazquez-Morón S, Larrauri A, Monge S; Working group for the surveillance and control of COVID-19. Varea-Jiménez E, et al. Among authors: vega piris l. Enferm Infecc Microbiol Clin (Engl Ed). 2024 Apr;42(4):187-194. doi: 10.1016/j.eimce.2022.11.021. Epub 2023 Feb 1. Enferm Infecc Microbiol Clin (Engl Ed). 2024. PMID: 36737369 Free PMC article.
[Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination].
Varea-Jiménez E, Cano EA, Vega-Piris L, Sánchez EVM, Mazagatos C, Rodríguez-Alarcón LGSM, Casas I, Moros MJS, Iglesias-Caballero M, Vazquez-Morón S, Larrauri A, Monge S. Varea-Jiménez E, et al. Among authors: vega piris l. Enferm Infecc Microbiol Clin. 2022 Dec 6. doi: 10.1016/j.eimc.2022.11.003. Online ahead of print. Enferm Infecc Microbiol Clin. 2022. PMID: 36506460 Free PMC article.
Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses.
Serra López-Matencio JM, Pérez García Y, Meca-Lallana V, Juárez-Sánchez R, Ursa A, Vega-Piris L, Pascual-Salcedo D, de Vries A, Rispens T, Muñoz-Calleja C. Serra López-Matencio JM, et al. Among authors: vega piris l. Front Neurol. 2021 Oct 7;12:716548. doi: 10.3389/fneur.2021.716548. eCollection 2021. Front Neurol. 2021. PMID: 34690914 Free PMC article.
Pharmacokinetic variability of eslicarbazepine in real clinical practice.
de Toledo M, Valladares-Salado L, Cebrian-Escudero J, Diaz-Perez C, de la Fuente E, Ferreiros R, Sanz-Sanz E, Vega-Piris L, Lagares A, Ovejero-Benito MC, Sobrado M. de Toledo M, et al. Among authors: vega piris l. Epilepsy Behav. 2021 Sep 11;124:108284. doi: 10.1016/j.yebeh.2021.108284. Online ahead of print. Epilepsy Behav. 2021. PMID: 34521058
38 results